Approval · Notice of Compliance 2064 · 1999
TEMODAL: Notice of Compliance 2064
Issued October 25, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2064
- Date
- October 25, 1999
- Company
- Schering Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic agent
Products in this notice
Medicinal ingredients
- TEMOZOLOMIDE 5 MG per CAP
- TEMOZOLOMIDE 20 MG per CAP
- TEMOZOLOMIDE 100 MG per CAP
- TEMOZOLOMIDE 250 MG per CAP